Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Orphan Designation Requests To Get Slower Reviews

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA can't keep pace with requests, placing more pressure on sponsors to ensure submissions are complete.

You may also be interested in...



US FDA's Orphan Drug Designation Reviews Often Don't Include Regulatory Histories, GAO Says

Lack of information may mean FDA cannot conduct a thorough review, but HHS argues that products usually are very early in development and therefore don't have a regulatory history to document.

US FDA Appoints Another Orphan Products Development Office Head Amid Growth Expectations

Janet Maynard will become acting Office of Orphan Products Development director at the end of October, the fourth head of the office in the last 10 months; staff is expected to grow and may begin to provide development advice.

US FDA's Acting Orphan Products Development Director Has Gene Therapy Background

Ilan Irony will take over as acting director of the Office of Orphan Products Development later this month.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS079401

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel